Synthetic Guaiacol Derivatives as Promising Myeloperoxidase Inhibitors Targeting Atherosclerotic Cardiovascular Disease
- 5 May 2020
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 15 (13) , 1187-1199
Abstract
Myeloperoxidase (MPO) is known to cause oxidative stress and inflammation leading to cardiovascular disease (CVD) complications. MPO‐mediated oxidation of lipoproteins leads to dysfunctional entities altering the landscape of lipoprotein functionality. The specificity of guaiacol derivatives toward preventing MPO‐mediated oxidation to limit MPO's harmful effects is unknown. Diligent in silico studies were accomplished for a portfolio of compounds with guaiacol as a building block. The compounds’ activity toward MPO inhibition was also validated. The role of these chemical entities in controlling MPO‐mediated oxidation of lipoproteins (LDL and HDL) was shown to agree with our approach of developing powerful MPO inhibitors. The mechanism of MPO inhibition was demonstrated to be reversible in nature. This study reveals that there is great potential for guaiacol derivatives as therapeutics for CVD by modulating lipid profiles, reducing atherosclerotic plaque burden, and subsequently optimizing cardiovascular functions.Keywords
This publication has 56 references indexed in Scilit:
- Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical StudiesMediators of Inflammation, 2013
- Anti-inflammatory effects of methoxyphenolic compounds on human airway cellsJournal of Inflammation, 2012
- Multitargeting by curcumin as revealed by molecular interaction studiesNatural Product Reports, 2011
- Vitamins C and E: Beneficial effects from a mechanistic perspectiveFree Radical Biology and Medicine, 2011
- Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and AtherosclerosisMediators of Inflammation, 2010
- Myeloperoxidase: An Oxidative Pathway for Generating Dysfunctional High-Density LipoproteinChemical Research in Toxicology, 2009
- Prodrugs for AminesMolecules, 2008
- Oxidative mechanisms and atherothrombotic cardiovascular diseaseDrug Discovery Today: Therapeutic Strategies, 2008
- Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous andhypobromous acidsFree Radical Biology and Medicine, 2001
- Mechanism of the Oxidation of 3,5,3‘,5‘-Tetramethylbenzidine by Myeloperoxidase Determined by Transient- and Steady-State KineticsBiochemistry, 1997